Cite
HARVARD Citation
Radhakrishna, G. et al. (n.d.). Can proton therapy offer a dosimetric advantage in difficult UK Commissioning through Evaluation (CtE) hepatocellular cancer SABR cases. Clinical oncology. pp. e4-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Radhakrishna, G. et al. (n.d.). Can proton therapy offer a dosimetric advantage in difficult UK Commissioning through Evaluation (CtE) hepatocellular cancer SABR cases. Clinical oncology. pp. e4-. [Online].